Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

91.03 +0.88 (+0.98%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 17, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	308,340
Open	88.35
Bid (Size)	88.00 (100)
Ask (Size)	95.00 (200)
Prev. Close	90.15
Today's Range	86.12 - 92.57
52wk Range	55.17 - 170.87
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Power Solutions Stock Up 140% as $6.36 Million Exit Follows 62% Sales Surge ↗

February 16, 2026

Power Solutions International designs and manufactures advanced engines and power systems for industrial and transportation markets.

Via The Motley Fool

Freshworks Falls 60% in a Year as $7.5 Million Sale Shrinks Stake to 3.1% of This Portfolio's Assets ↗

February 16, 2026

This SaaS firm delivers cloud-based business software worldwide, focusing on subscription-driven customer and IT service solutions.

Via The Motley Fool

Performance

YTD	-31.2%	-31.2%
1 Month	-8.7%	-8.7%
3 Month	-28.3%	-28.3%
6 Month	-24.6%	-24.6%
1 Year	-19.3%	-19.3%

More News

Air Lease Stock Up 43% as Investor Trims $6.9 Million Stake Despite $1 Billion Profit Year ↗

February 16, 2026

Via The Motley Fool

Five9 Stock Down 60% This Past Year, but One Investor Just Lifted Stake With $3.5 Million Buy ↗

February 16, 2026

Via The Motley Fool

Freshworks Stock Down 60% in One Year as Revenue Jumps 16% and One Investor Sells $7 Million in Shares ↗

February 16, 2026

Via The Motley Fool

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health

February 11, 2026

From GeneDx

Via Business Wire

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

February 03, 2026

From GeneDx

Via Business Wire

The Great Rotation: Small-Caps Stand Tall as AI Exhaustion Triggers Tech Rout

January 29, 2026

Via MarketMinute

The Great Rotation of 2026: Why Wall Street is Abandoning Big Tech for Main Street Small Caps

January 28, 2026

Via MarketMinute

The Great AI Pivot: From Massive Build-Out to the Era of Operational ROI

January 27, 2026

Via MarketMinute

The Great Rotation: Wall Street’s ‘Earnings Handoff’ Moves from Silicon Valley to Main Street

January 26, 2026

Via MarketMinute

The Great Rotation: Small-Caps Set to Outpace ‘Magnificent 7’ in Historic Earnings Handoff

January 26, 2026

Via MarketMinute

Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗

January 25, 2026

Via The Motley Fool

Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗

January 24, 2026

Via The Motley Fool

The Great Rotation of 2026: Why Wall Street is Betting Big on the Russell 2000

January 22, 2026

Via MarketMinute

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

January 15, 2026

From Halper Sadeh LLC

Via Business Wire

The Great Rotation: Small-Cap Stocks Surge in Early 2026 as Market Leadership Broadens

January 13, 2026

Via MarketMinute

The Great Rotation: Small-Caps Log Longest Winning Streak Against S&P 500 Since 2019

January 12, 2026

Via MarketMinute

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

January 12, 2026

From GeneDx

Via Business Wire

GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset

January 08, 2026

From GeneDx

Via Business Wire

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

January 07, 2026

From GeneDx

Via Business Wire

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

January 06, 2026

From GeneDx

Via Business Wire

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

January 05, 2026

From GeneDx

Via Business Wire

BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era

January 02, 2026

Via MarketMinute

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

December 30, 2025

From GeneDx

Via Business Wire

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?

Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.

What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?

GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?

The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market

What is the current price of GeneDx Holdings Corp. - Class A Common Stock?

The current price of GeneDx Holdings Corp. - Class A Common Stock is 91.03

When was GeneDx Holdings Corp. - Class A Common Stock last traded?

The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 02/17/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.